Renbio
Renbio is a gene Therapy Directing Antibody Creation in vivo.
1
Funding Rounds
$24.0m
Money raised
Overview
Renbio is a gene Therapy Directing Antibody Creation in vivo.
- Website:
- Social accounts: linkedin
Funding series
Funding Series Analysis
The company Renbio has raised a total of $24m in funding over 1 rounds.
Key Insights:
- Renbio Series A round, May 2021: $24m
Renbio Series A round, May 2021
$24m
Industries
Renbio is active in the following industries: